Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis

Area of Science:

• Neurology
• Neurosurgery
• Medical Devices

Background:

• Drug-resistant epilepsy affects adults and children when conventional treatments fail.
• Surgical options like vagus nerve stimulation (VNS) and deep brain stimulation (DBS) offer alternatives for seizure control.
• Evaluating the efficacy and safety of VNS and DBS is crucial for treatment selection.

Purpose of the Study:

• To assess the effectiveness of VNS and DBS in managing drug-resistant epilepsy in pediatric and adult populations.
• To analyze seizure frequency, health resource utilization, and safety profiles of VNS and DBS.
• To conduct a cost-effectiveness analysis of these neuromodulation therapies.

Main Methods:

• A comprehensive literature search was conducted across major databases (MEDLINE, EMBASE, Cochrane) for studies published between 2007 and 2012.
• Included study designs encompassed systematic reviews, meta-analyses, randomized controlled trials (RCTs), and observational studies.
• Studies focused on VNS and DBS (specifically anterior nucleus of thalamus) for epilepsy treatment in adults and children were analyzed.

Main Results:

• DBS and VNS demonstrated significant seizure frequency reduction in adults.
• VNS led to decreased hospitalizations and emergency department visits for both adults and children.
• VNS in children did not show a significant difference in seizure frequency, and data on DBS in children and health resource use for DBS were lacking.

Conclusions:

• Evidence suggests DBS and VNS are effective for seizure reduction in adult drug-resistant epilepsy.
• VNS shows benefits in reducing healthcare utilization for children, though seizure reduction efficacy is less certain.
• Despite procedural risks, long-term adverse events for both VNS and DBS appear limited, but data gaps exist, particularly for pediatric DBS.